BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
목요일, 9월 24

Apimeds Pharmaceuticals Us Inc

APUSAMEX
Trade with Public
Trade with Public
$6.02
3.73162.88%
마지막 업데이트: Sep 24, 1:12 PM
PRO
변동 이유?:Apimeds Pharmaceuticals shares are trading higher after the company announc...
개요뉴스실적 전망재무심리지분 현황비교주식 보고서

Apimeds Pharmaceuticals Earnings & Forecasts

Apimeds Pharmaceuticals (APUS) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

Quarterly Revenue (Billions)

Apimeds Pharmaceuticals Guidance

Recent Earnings Results

MetricQ2 '26Q1 '26Q4 '25Q3 '25
Earnings Per Share (Non-GAAP)
Estimate————
Actual$-11.77$-22.60$-8.00$-14.00
Surprise————
Revenue
Estimate————
Actual$0$0$0$0
Surprise————

Earnings & Guidance News

PRO
Apimeds Pharmaceuticals Q1 EPS $(2.26) Down From $(0.50) YoY

Apimeds Pharmaceuticals (AMEX:APUS) reported quarterly losses of $(2.26) per share. This is a 352 percent decrease over losses of $(0.50) per share from the same period last year.
Benzinga Newsdesk

PRO
Apimeds Pharmaceuticals Q4 EPS $(0.80) Down From $(0.50) YoY

Apimeds Pharmaceuticals (AMEX:APUS) reported quarterly losses of $(0.80) per share. This is a 60 percent decrease over losses of $(0.50) per share from the same period last year.
Benzinga Newsdesk

PRO
Apimeds Pharmaceuticals Q2 EPS $(0.26) Down From $(0.06) YoY

Apimeds Pharmaceuticals (AMEX:APUS) reported quarterly losses of $(0.26) per share. This is a 333.33 percent decrease over losses of $(0.06) per share from the same period last year.
Benzinga Newsdesk

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

BenzingaBenzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved